Halaven 0.44 mg Injection
Brand Name: Halaven 0.44mg/ml
Composition: Eribulin 0.44mg/ml
Marketed by: Eisai Co.
Form: Solution for Injection
Packing: Pack of 1 vial of 2ml (equivalent to 0.88mg eribulin)
IS HALAVEN INJECTION?
Halaven is a medicine composition of Eribulin that interferes with the growth and spread of cancer cells in the body.
USES OF HALAVEN INJECTION:
Eribulin is used to treat breast cancer that has spread to other parts of the body. Eribulin is also used to treat liposarcoma, a rare type of cancer that develops in fatty tissue anywhere in the body.
Halaven is used to treat breast cancer that has spread to other parts of the body.
POSSIBLE SIDE EFFECTS:
Along with its needed effects, eribulin (the active ingredient contained in Halaven) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
chest pain, severe dizziness, fast or pounding heartbeats; numbness, tingling, or burning pain in your hands or feet; pain or burning when you urinate; low potassium--confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling; or severe skin reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain followed by a red or purple skin rash that spreads and causes blistering and peeling.
You should not use eribulin if you are allergic to it.
To make sure eribulin is safe for you, tell your doctor if you have: liver disease; kidney disease; heart disease; peripheral vascular disease such as Reynaud’s syndrome; or an electrolyte imbalance.
Do not use eribulin if you are pregnant.
Do not breast-feed while you are using eribulin.